Dova Pharmaceuticals, Inc. announced that Jason Levine joined as Vice President of Marketing. He has over 25 years of industry experience across multiple therapeutic areas and comes from Gilead Sciences, where he spent the last 13 years in a variety of commercial leadership roles. Additionally, the company announced that Ilija Zlatar joined Dova as Head of U.S. Sales. Ilija comes from Gilead, where he too held a variety of commercial leadership roles in sales and marketing. Ilija was responsible for the promotional launch of Vemlidy in chronic hepatitis B and most recently was leading commercialization efforts for their NASH program in the U.S.